Information for authors

Acta Pharmaceutica Sinica  started its publication in July 1953 following its predecessor “Chinese Journal of Pharmaceutical Sciences” which was started in 1936.  It is devoted to original research articles on pharmaceutical sciences including pharmacology, toxicology, pharmacy, pharmacognosy, antibiotics, chemistry of natural products, pharmaceutical chemistry and pharmaceutical analysis. Research articles, communications, reviews and commentaries introducing new theories and new technologies are also published. Readers of Acta Pharmaceutica Sinica are supposed to be mainly those involved in scientific research and those pertaining to higher education. Papers in Acta Pharmaceutica Sinica are mainly written in Chinese with an abstract in English. However, all tables, figures and references are in English. Papers in English are also published.

Acta Pharmaceutica Sinica is included in many important index systems all over the world, such as Medline, CA, Scifinder Scholar, Scopus, BA, AJ(Russia), CABI, IPA, IC, IPA, CSA, CBST (Japan) and Ulrich’s International Periodicals Directory, etc. Acta Pharmaceutica Sinica is also one of the important journals, primarily supported by China Assocation for Science and Technology Foundation. The total citation rate and impact factor of Acta Pharmaceutica Sinica in 2010 were 2916, and 1.085, respectively.

Acta Pharmaceutica Sinica won the 1st “National Prize for Chinese Journals” in 1999 and was selected as the “Journal of High Popularity and High Academic Level” in the “Phalanx of Chinese Journals” in 2001. It also won “ National Prize for Chinese Journals (100 Leading Science and Technological Journals)” for nine times from 2002 to 2010, the 3rd “ Prize for Chinese Excellent Science and Technological Journals” in 2002 and “The Chinese Government Award for Publishing” for Journals in 2010.

Chinese Chemical Letters (CCL) was founded in July 1990. The journal publishes preliminary accounts in the whole field of chemistry, satisfying a real and urgent need for the dissemination of research results, especially hot topics. In a way, it has become a show window of important chemical literature. For this purpose, articles in the journal are only written in English. The journal does not accept articles previously published or scheduled to be published. After publication of the communication in the journal, it can be expanded to a full paper and published elsewhere. Authors are requested to send papers of 2-4 pages. Readers of the CCL are supposed to be mainly those involved in scientific research and those pertaining to higher education.

CCL is an official journal of the Chinese Chemical Society, superintended by the China Association for Science and Technology, and undertaken by the Institute of Materia Medica of the Chinese Academy of Medical Sciences and Peking Union Medical College.

CCL is published monthly with 126 pages in each issue. The Editor-in-Chief is Professor Xiao-tian Liang. The editorial board consists of 21 professors from research institutes or departments of chemical sciences in universities. The papers published in the CCL must be reviewed by at least two members of the editorial board.

The journal has been indexed by Science Citation Index-Expanded since 1993. The total citation rate and impact factor of the CCL in 2010 were 2063 and 0.775 respectively. The journal is also indexed or abstracted by Chemical Abstract, Chemical Citation Index, Research Alert, etc.

Journal of Asian Natural Products Research (JANPR) was founded in October 1998. The Journal  publishes chemical and pharmaceutical studies in the English language in the field of natural product research on Asian ethnic medicine. The journal will publish work from scientists in Asian countries, e.g. China, Japan, Korea and India, including contributions from other countries concerning natural products of Asia. 

The journal is chemistry-orientated. Major fields to be covered are: isolation and structural elucidation of natural constituents (including those for non-medical uses), synthesis and transformation (including biosynthesis and biotransformation) of natural products, pharmacognosy, and allied topics. Biological evaluation of crude extracts are acceptable only as supporting data for pure isolates with well-characterized structures

The journal has been indexed by Science Citation Index-Expanded since 1999.  

Acta Pharmaceutica Sinica B (APSB) is a bimonthly English peer-reviewed online journal in ScienceDirect (http://ees.elsevier.com/apsb), which publishes significant original research articles, rapid communications and high quality reviews of recent advances in all areas of pharmaceutical sciences — including pharmacology, pharmaceutics, medicinal chemistry, natural products, pharmacognosy, pharmaceutical analysis, pharmacokinetics and drug metabolism.

APSB is a part of the series Acta Pharmaceutica Sinica, which was founded in 1953, and indexed in Chemical Abstracts, Index Medicus, SciFinder Scholar, Biological Abstracts, International Pharmaceutical Abstracts, Cambridge Scientific Abstracts, Current Bibliography on Science and Technology, etc. It is sponsored by Insititute of Materia Medica, Chinese Academy of Medical Sciences and Chinese Pharmaceutical Association, produced and hosted by Elsevier B. V.